Combination treatment with HDAC inhibitors plus PI3K/Akt pathway inhibition also potentiates the targeting effect of tumor angiogenesis [30], invasion, and migration [31], indicating MPT0E028's wide-ranging usefulness. The gene discussed is AKT1; the disease is neoplasm.